171 related articles for article (PubMed ID: 28296603)
1. Another Senseless Death - The Case for Supervised Injection Facilities.
Wakeman SE
N Engl J Med; 2017 Mar; 376(11):1011-1013. PubMed ID: 28296603
[No Abstract] [Full Text] [Related]
2. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
[TBL] [Abstract][Full Text] [Related]
3. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
Darke S; Ross J; Lynskey M; Teesson M
Drug Alcohol Depend; 2004 Jan; 73(1):1-10. PubMed ID: 14687954
[TBL] [Abstract][Full Text] [Related]
4. New hope for unsanctioned safe injection site.
Glauser W
CMAJ; 2018 Jan; 190(3):E90-E91. PubMed ID: 29358208
[No Abstract] [Full Text] [Related]
5. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study.
Mendelson JH; Mello NK; Teoh SK; Kuehnle J; Sintavanarong P; Dooley-Coufos K
NIDA Res Monogr; 1990; 105():196-202. PubMed ID: 1875999
[No Abstract] [Full Text] [Related]
7. New treatment gives hope to East Africa's drug users.
Bull World Health Organ; 2013 Feb; 91(2):89-90. PubMed ID: 23554520
[TBL] [Abstract][Full Text] [Related]
8. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
McKeganey N; Russell C; Cockayne L
J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
[TBL] [Abstract][Full Text] [Related]
9. New Strategies Are Needed to Stop Overdose Fatalities: The Case for Supervised Injection Facilities.
Gaeta JM; Racine M
Ann Intern Med; 2018 May; 168(9):664-665. PubMed ID: 29404601
[No Abstract] [Full Text] [Related]
10. Injection site gets 16-month extension.
Jones D
CMAJ; 2006 Oct; 175(8):859. PubMed ID: 17030931
[No Abstract] [Full Text] [Related]
11. [Supervised injection. Under the watchful eye of nurses].
Gagné L
Perspect Infirm; 2013; 10(2):17-20. PubMed ID: 23539859
[No Abstract] [Full Text] [Related]
12. Pharmacological maintenance treatments of opiate addiction.
Bell J
Br J Clin Pharmacol; 2014 Feb; 77(2):253-63. PubMed ID: 23210630
[TBL] [Abstract][Full Text] [Related]
13. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
Bramness JG; Bachs LC; Waal H
Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
[TBL] [Abstract][Full Text] [Related]
14. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.
Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH
Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091
[TBL] [Abstract][Full Text] [Related]
15. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
16. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
[TBL] [Abstract][Full Text] [Related]
17. Intravenous drug use, methadone, and AIDS: ask not for whom the bell tolls.
Stimmel B
J Addict Dis; 1993; 12(1):1-5. PubMed ID: 8424962
[No Abstract] [Full Text] [Related]
18. Adolescents at risk: pain pills to heroin: part II.
Fogger S; McGuinness TM
J Psychosoc Nurs Ment Health Serv; 2015 Feb; 53(2):27-30. PubMed ID: 25654572
[TBL] [Abstract][Full Text] [Related]
19. Medical mismanagement in public methadone programs.
Blansfield HN
Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
[No Abstract] [Full Text] [Related]
20. Predicting biopsychosocial outcomes for heroin users in primary care treatment: a prospective longitudinal cohort study.
Parmenter J; Mitchell C; Keen J; Oliver P; Rowse G; Neligan I; Keil C; Mathers N
Br J Gen Pract; 2013 Jul; 63(612):e499-505. PubMed ID: 23834887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
